 | Up a level |
Ferreri, Andreas J M; Illerhaus, Gerald; Doorduijn, Jeanette K; Auer, Dorothee P; Bromberg, Jacoline E C; Calimeri, Teresa; Cwynarski, Kate; Fox, Christopher P; Hoang-Xuan, Khê; Malaise, Denis; Ponzoni, Maurilio; Schorb, Elisabeth; Soussain, Carole; Specht, Lena; Zucca, Emanuele; Buske, Christian; Jerkeman, Mats; Dreyling, Martin (2024). Primary central nervous system lymphomas: EHA-ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. HemaSphere, 8(6) Wolters Kluwer Health 10.1002/hem3.89
Bonfiglio, Ferdinando; Bruscaggin, Alessio; Guidetti, Francesca; Terzi di Bergamo, Lodovico; Faderl, Martin Richard; Spina, Valeria; Condoluci, Adalgisa; Bonomini, Luisella; Forestieri, Gabriela; Koch, Ricardo; Piffaretti, Deborah; Pini, Katia; Pirosa, Maria C; Cittone, Micol Giulia; Arribas, Alberto; Lucioni, Marco; Ghilardi, Guido; Wu, Wei; Arcaini, Luca; Baptista, Maria Joao; ... (2022). Genetic and Phenotypic Attributes of Splenic Marginal Zone Lymphoma. Blood, 139(5), pp. 732-747. American Society of Hematology 10.1182/blood.2021012386
Rinaldi, Andrea; Mian, Michael; Chigrinova, Ekaterina; Arcaini, Luca; Bhagat, Govind; Novak, Urban; Rancoita, Paola M. V.; De Campos, Cassio P.; Forconi, Francesco; Gascoyne, Randy D.; Facchetti, Fabio; Ponzoni, Maurilio; Govi, Silvia; Ferreri, Andrés J. M.; Mollejo, Manuela; Piris, Miguel A.; Baldini, Luca; Soulier, Jean; Thieblemont, Catherine; Canzonieri, Vincenzo; ... (2011). Genome-wide DNA profiling of marginal zone lymphomas identifies subtype-specific lesions with an impact on the clinical outcome. Blood, 117(5), pp. 1595-1604. Washington, D.C.: American Society of Hematology 10.1182/blood-2010-01-264275
